NovaBay Pharma

NovaBay Pharmaceuticals (NYSE American: NBY) is becoming Stablecoin Development Corporation (NYSE American: SDEV). We're changing our name and ticker to reflect what we're building: the premier public market vehicle for exposure to the stablecoin economy. Since closing a ~$134M private placement in January 2026 with R01 Fund LP, @hiFramework , @tether , and the Sky Frontier Foundation, we've accumulated over 2 billion SKY tokens (~8.78% of total supply) and begun generating staking rewards through the @SkyEcosystem Protocol. Trading under SDEV begins April 3, 2026.

Full Press Release: globenewswire.com/news-release/2… $NBY $SDEV $SKY $USDS

NovaBay Pharmaceuticals (NYSE American: NBY) is becoming Stablecoin Development Corporation (NYSE American: SDEV). We're changing our name and ticker to reflect what we're building: the premier public market vehicle for exposure to the stablecoin economy. Since closing a ~$134M private placement in January 2026 with R01 Fund LP, @hiFramework , @tether , and the Sky Frontier Foundation, we've accumulated over 2 billion SKY tokens (~8.78% of total supply) and begun generating staking rewards through the @SkyEcosystem Protocol. Trading under SDEV begins April 3, 2026.

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders. bit.ly/3DyGCa5 $NBY

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal. bit.ly/3E3RxZg $NBY

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting. bit.ly/3OLTZ96 $NBY

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand. bit.ly/3YNXwIE $NBY

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results bit.ly/3AmCzML $NBY

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price. bit.ly/3ChRcBq $NBY

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC. bit.ly/40mNU9S $NBY

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets bit.ly/4guPwUO $NBY

Dry eye happens when your eyes don't produce the right amount of tears, which could leave your eyes feeling dry, itchy, sore, or watery. For more information on #dryeye symptoms, causes, and potential treatments, visit the @AvenovaEyeCare website: bit.ly/3UI36vF $NBY

NovaBay is addressing the large, unmet, therapeutic need of the global #eyecare and #woundcare markets with its pure, proprietary, FDA-cleared, stable form of hypochlorous acid (HOCl). bit.ly/3etwx1N $NBY

ICYMI NovaBay hosted a conference call to discuss second quarter 2024 financial results and to provide a business update. Listen to a replay here: bit.ly/3SN17nP $NBY

NovaBay reported financial results for the three and six months ended June 30, 2024. NovaBay management will host an investment community conference call to discuss its Q2 2024 results and to provide a business update today at 4:30 p.m. ET. bit.ly/3Ar5m2o $NBY

Reminder: NovaBay will hold a conference call to discuss its Q2 2024 financial results today at 4:30 p.m. ET. For dial-in and webcast details: bit.ly/46t0N3s $NBY

NovaBay's Avenova® lid & lash solution is lab tested and clinically proven to help relieve chronic eye conditions like #dryeye, blepharitis, meibomian gland dysfunction, contact lens intolerance & inflammation. Find the full line: bit.ly/3DWi6xj $NBY

NovaBay will report financial results for the three and six months ended June 30, 2024 after market close on Tuesday, August 13, 2024 and will hold an investment community conference call that day beginning at 4:30 p.m. E.T. Find details: bit.ly/46t0N3s $NBY

NovaBay CEO, Justin Hall, comments on the Company's record sales of @AvenovaEyeCare®-branded #eyecare products during the 2024 #AmazonPrimeDay event: bit.ly/4fskRam $NBY

@eyenovia's Clobetasol is expected to be launched in August to U.S. #eyecare professionals. Once available, NovaBay will conduct outreach through its telephone-based physician dispensed channel to supplement geographic areas not covered by $EYEN. bit.ly/3L8kSSK $NBY